MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

Scope & Guideline

Advancing Knowledge on Menopause Management

Introduction

Delve into the academic richness of MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN1072-3714
PublisherLIPPINCOTT WILLIAMS & WILKINS
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1994 to 2024
AbbreviationMENOPAUSE / Menopause-J. N. Am. Menopause Soc.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressTWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103

Aims and Scopes

The journal 'Menopause: The Journal of the North American Menopause Society' focuses on the comprehensive study of menopause, addressing various aspects including clinical, psychological, and social dimensions of women's health during this transition. Its scope encompasses a wide array of research methodologies, from clinical trials and epidemiological studies to qualitative research and systematic reviews.
  1. Clinical Management of Menopausal Symptoms:
    Research related to the clinical management of symptoms associated with menopause, including hormone therapy, non-hormonal treatments, and alternative therapies.
  2. Impact on Quality of Life:
    Studies focusing on how menopause impacts women's quality of life, including physical, psychological, and social dimensions.
  3. Epidemiological Studies:
    Investigating the prevalence, risk factors, and outcomes associated with menopausal symptoms across diverse populations.
  4. Innovative Therapies and Interventions:
    Exploration of new treatment options for menopausal symptoms, including pharmacological and non-pharmacological interventions.
  5. Psychosocial Aspects of Menopause:
    Research examining the psychological and social factors influencing women's experiences during menopause.
  6. Health Disparities:
    Studies addressing how socioeconomic, racial, and cultural factors affect women's health outcomes during menopause.
  7. Sexual Health and Functioning:
    Research focusing on the sexual health challenges faced by women during and after the menopause transition.
The journal has seen a rise in publications focusing on various emerging themes that reflect contemporary issues and advances in menopausal research. These trends highlight the evolving landscape of women's health as it pertains to menopause.
  1. Non-Hormonal Treatment Options:
    An increasing number of studies are exploring non-hormonal alternatives for managing menopausal symptoms, reflecting a shift towards personalized medicine and patient preference.
  2. Mental Health and Menopause:
    Research highlighting the psychological aspects of menopause, including the impact of menopausal symptoms on mental health, is gaining traction, recognizing the importance of addressing mental well-being during this transition.
  3. Digital Health Innovations:
    The integration of technology in menopause management, including telehealth and mobile health applications, is emerging as a significant area of research, providing new avenues for patient education and symptom management.
  4. Cultural Influences on Menopause Experience:
    Studies examining the cultural perceptions and experiences of menopause among diverse populations are on the rise, emphasizing the need for culturally sensitive approaches in menopause care.
  5. Genitourinary Syndrome of Menopause (GSM):
    There is an increasing focus on GSM, with research addressing its prevalence, impact on quality of life, and treatment options, reflecting a growing recognition of this condition's significance.
  6. Intersection of Menopause and Chronic Conditions:
    Emerging research is increasingly examining the interplay between menopause and chronic health conditions such as cardiovascular disease, diabetes, and obesity, highlighting the multifaceted nature of women's health.

Declining or Waning

While the journal continues to publish a broad range of topics concerning menopause, certain themes have shown a decline in prominence over time. This may reflect evolving research interests and societal changes regarding menopause.
  1. Traditional Hormone Replacement Therapy (HRT):
    There has been a noticeable decrease in studies focusing on conventional HRT as new non-hormonal treatments gain popularity and acceptance among clinicians and patients.
  2. Focus on Surgical Menopause:
    Research specifically addressing surgical menopause is declining, potentially due to a broader focus on non-surgical management options and a shift towards understanding menopause as a natural transition rather than solely a surgical outcome.
  3. Limited Scope on Menopausal Age and Timing:
    There appears to be a waning interest in studies that solely focus on the age of onset of menopause, as more comprehensive studies are emerging that consider multiple factors influencing women's health across the menopausal transition.

Similar Journals

GYNECOLOGICAL ENDOCRINOLOGY

Innovating Solutions for Gynecological Endocrinology
Publisher: TAYLOR & FRANCIS LTDISSN: 0951-3590Frequency: 12 issues/year

GYNECOLOGICAL ENDOCRINOLOGY is a prestigious open-access journal published by Taylor & Francis Ltd, focusing on the dynamic fields of endocrinology, obstetrics, and gynecology. With its ISSN of 0951-3590 and E-ISSN of 1473-0766, this journal provides a vital platform for the dissemination of high-quality research and advancements in gynecological endocrinology since its inception in 1987. Notably, it attained an Open Access status in 2023, enhancing its reach and accessibility to researchers and practitioners worldwide. The journal is renowned for its rigorous peer-review process and holds significant standing with a Q2 ranking in Obstetrics and Gynecology and a Q3 ranking in Endocrinology, Diabetes, and Metabolism, as of 2023. It is indexed with commendable Scopus ranks in various medical domains, offering a reliable resource for current methodologies and future directions in gynecological health. With the growing emphasis on women's health and endocrinological research, GYNECOLOGICAL ENDOCRINOLOGY serves as an essential repository for innovative studies, clinical insights, and emerging therapeutic strategies, making it an invaluable resource for researchers, clinicians, and students alike.

Journal of Mid-life Health

Pioneering Discussions on Health in Middle Age
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0976-7800Frequency: 4 issues/year

The Journal of Mid-life Health, published by Wolters Kluwer Medknow Publications, serves as a crucial platform for researchers and practitioners focusing on the multifaceted aspects of health during middle age. With a commitment to open access since 2010, this journal ensures that valuable research is available to a broad audience, fostering scholarly discussion and innovation in the field. Its ISSN is 0976-7800 and E-ISSN 0976-7819, making it easily identifiable in academic databases. Currently rated in the Q3 quartile in both health (social science) and miscellaneous medicine categories for 2023, the journal is positioned among the top tier of its peers, reflecting its significance in these domains. The journal ranks #222 in the Medicine (miscellaneous) category and #223 in Social Sciences (health) according to Scopus, showcasing its impact and relevance in contemporary discourse around mid-life health challenges. Researchers, health professionals, and students alike can benefit from the journal’s comprehensive articles, which span a variety of topics essential for understanding and improving health outcomes in middle age.

Journal of Diabetes Investigation

Pioneering insights for improved diabetes care.
Publisher: WILEYISSN: 2040-1116Frequency: 6 issues/year

Journal of Diabetes Investigation is a prestigious open-access journal published by WILEY, dedicated to advancing knowledge in the fields of Endocrinology, Diabetes, and Metabolism. With its ISSN 2040-1116 and E-ISSN 2040-1124, the journal provides a vital platform for researchers, healthcare professionals, and students to disseminate high-quality research, foster innovative ideas, and engage with cutting-edge developments in diabetes investigation. Since its inception in 2010, the journal has established a solid reputation, ranking in Q2 for Endocrinology and Diabetes and Metabolism, and Q1 for both Internal Medicine and Miscellaneous Medicine categories in 2023. Its Scopus rankings further underscore its impact, notably at the 76th percentile in Internal Medicine. The open access model, adopted in 2014, ensures that vital information is freely available, promoting global collaboration and knowledge sharing. The journal is not only a reflection of Australia's commitment to medical research but also a beacon for advancements that can ultimately enhance patient outcomes in diabetes care.

CLINICAL AND EXPERIMENTAL MEDICINE

Advancing Health Sciences Through Rigorous Research
Publisher: SPRINGER-VERLAG ITALIA SRLISSN: 1591-8890Frequency: 4 issues/year

Clinical and Experimental Medicine is a leading journal published by Springer-Verlag Italia SRL, dedicated to advancing the understanding of the intricate relationships between biomedical research and clinical applications. Since its inception in 2001, the journal has garnered an esteemed reputation, achieving Q1 quartile rankings in 2023 in both Biochemistry, Genetics and Molecular Biology (miscellaneous) and Medicine (miscellaneous), establishing itself as a key resource for researchers and practitioners alike. With an impactful contribution reflected in its Scopus rankings, particularly a #81/221 rank in the General Biochemistry, Genetics and Molecular Biology category, Clinical and Experimental Medicine serves as a rich platform for peer-reviewed articles that bridge theory and practice across diverse medical disciplines. The journal embraces Open Access options, broadening the accessibility of groundbreaking research to a global audience, thereby fostering collaboration and innovation. Located in Milan, Italy, it continually endeavors to enrich knowledge and share valuable insights essential for the advancement of health sciences.

Multiple Sclerosis Journal-Experimental Translational and Clinical

Innovating Insights in Neurology and Neuroscience
Publisher: SAGE PUBLICATIONS INCISSN: Frequency: 1 issue/year

Multiple Sclerosis Journal-Experimental Translational and Clinical, published by SAGE Publications, Inc., is an essential open-access platform since 2015 dedicated to advancing research in the field of multiple sclerosis and related neurological disorders. With an ISSN of N/A and an E-ISSN of 2055-2173, the journal aims to bridge the gap between experimental studies and clinical applications, offering valuable insights into cellular and molecular neuroscience as well as clinical neurology. The journal holds a reputable Q3 ranking in Cellular and Molecular Neuroscience and a Q2 ranking in Neurology (Clinical) for 2023, indicating its significant contribution to these fields. Positioned at the intersection of scientific discovery and clinical practice, the Multiple Sclerosis Journal serves as an indispensable resource for researchers, clinicians, and students dedicated to improving outcomes for individuals affected by multiple sclerosis and related disorders. With a Scopus ranking of #163/400 in Medicine - Neurology and #67/97 in Neuroscience, this journal continues to play a pivotal role in shaping the future of neurological research and therapy.

Gynecologic Oncology Reports

Connecting scholars to enhance women's health globally.
Publisher: ELSEVIER SCIENCE INCISSN: 2352-5789Frequency: 4 issues/year

Gynecologic Oncology Reports is a pivotal interdisciplinary journal published by Elsevier Science Inc. that has been dedicated to advancing the understanding of women's health since its inception in 2014. This Open Access journal, available to a global audience, facilitates the dissemination of high-quality research in the fields of gynecology and oncology, allowing for the free exchange of knowledge and fostering collaboration among researchers, clinicians, and students. With an impact factor reflective of its commitment to clinical relevance, Gynecologic Oncology Reports holds a Q3 ranking in both obstetrics and gynecology as well as oncology categories, contributing to its visibility and the prestige of published work. Situated in the Netherlands and operating within an open-access framework, it ensures that critical findings and advancements reach a broad readership. The journal serves as a vital resource for those aiming to stay at the forefront of gynecologic oncology, promoting improved patient outcomes through cutting-edge research. As it converges towards its 10th anniversary in 2024, Gynecologic Oncology Reports continues to be an essential platform for scholarly communication in this important field.

JAMA Oncology

Pioneering insights in oncology and cancer treatment.
Publisher: AMER MEDICAL ASSOCISSN: 2374-2437Frequency: 12 issues/year

JAMA Oncology, published by the American Medical Association, stands at the forefront of cancer research as a premier peer-reviewed journal in the field. With an ISSN of 2374-2437 and an impressive impact factor reflecting its critical insights, the journal has achieved a top-tier position, being ranked in the Q1 quartile for both Cancer Research and Oncology as of 2023, and demonstrating exceptional performance in Medicine as well. Spanning a converged publication period from 2015 through 2024, JAMA Oncology publishes cutting-edge research, clinical trials, and reviews that are pivotal in advancing our understanding and treatment of cancer. The journal's Scopus ranks highlight its global impact, placing it in the top deciles within its categories, ensuring that it remains a vital resource for oncologists, researchers, and students alike. While it currently does not offer open access, JAMA Oncology continues to provide invaluable contributions to the scientific community, promoting a deeper understanding of oncological challenges and breakthroughs.

JOURNAL OF DERMATOLOGY

Shaping the future of skin health through impactful research.
Publisher: WILEYISSN: 0385-2407Frequency: 12 issues/year

The Journal of Dermatology, published by Wiley, is a premier academic journal dedicated to advancing the field of dermatology, with its esteemed reputation reflected in its Q1 ranking in Dermatology and a remarkable Q2 ranking in Miscellaneous Medicine as of 2023. Since its inception in 1974, the journal has become a vital resource for researchers, clinicians, and students alike, covering pioneering studies and cutting-edge advancements in skin health and disease. With a Scopus rank of #32 out of 142 in the Dermatology category, placing it in the 77th percentile, the journal underscores its commitment to fostering knowledge and innovation within the dermatological community. Although the journal operates under a subscription model, it remains an essential platform for disseminating impactful research that shapes clinical practice and enhances patient care. For anyone invested in dermatological sciences, Journal of Dermatology serves as a key publication where critical insights and developments are regularly showcased.

Gynakologische Endokrinologie

Empowering Research for a Healthier Future
Publisher: SPRINGER HEIDELBERGISSN: 1610-2894Frequency: 4 issues/year

Gynakologische Endokrinologie is a pivotal journal published by SPRINGER HEIDELBERG, dedicated to advancing the fields of endocrinology, obstetrics, gynecology, reproductive medicine, and pediatrics. With an ISSN of 1610-2894, this journal serves as a valuable platform for researchers and practitioners to disseminate their findings and explore emerging trends and treatments in the realm of women's health and endocrine disorders. Though currently positioned in the Q4 quartile across relevant categories, its mission is to foster scholarly discourse that bridges gaps in knowledge and enhances clinical practices. With a commitment to quality research, it provides a forum for innovative studies and case reports that could influence future healthcare strategies. Positioned in Germany, Gynakologische Endokrinologie aims to cater to a global audience, enhancing knowledge and collaboration in critical areas impacting women's health and hormone-related conditions.

Journal of Cancer Survivorship

Empowering Cancer Survivors Through Research
Publisher: SPRINGERISSN: 1932-2259Frequency: 4 issues/year

The Journal of Cancer Survivorship, published by SPRINGER, serves as a premier platform for research dedicated to the complex realities faced by cancer survivors. Established in 2007, this esteemed journal focuses on the multifaceted aspects of oncology care, particularly within the nursing domain, reflecting its significance with a 2023 Q1 ranking in both Oncology and Oncology (nursing) categories. Additionally, it boasts impressive Scopus rankings, positioning it in the top tier of nursing and oncology fields. Targeted towards researchers, healthcare professionals, and students, the journal emphasizes advancements in survivorship care, psychosocial support, and health-related quality of life post-cancer treatment. With no open access option, the journal maintains a high standard of scholarly communications while ensuring rigorous peer review processes, making it an indispensable resource in the evolving landscape of cancer survivorship studies.